Canature Health Technology Co., Ltd. (SHE:300272)
China flag China · Delayed Price · Currency is CNY
5.12
-0.07 (-1.35%)
Nov 18, 2026, 11:54 AM CST

SHE:300272 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,7841,7961,6791,6591,6451,489
Other Revenue
45.4145.4144.9612.5115.6722.71
1,8301,8411,7241,6721,6611,511
Revenue Growth
-1.31%6.77%3.14%0.67%9.87%27.97%
Cost of Revenue
1,1181,1291,0641,0561,1121,010
Gross Profit
711.18711.46660.01615.87548.75501.96
Selling, General & Admin
433.97423.91425.75384.05346.17304.05
Research & Development
83.2181.5581.976563.9451.49
Other Operating Expenses
4.915.255.615.839.043.26
Operating Expenses
522.88511.29513.24457.05419.71361.57
Operating Income
188.3200.17146.77158.82129.04140.39
Interest Expense
-43.14-44.87-41.84-28.44-16.85-16.28
Interest & Investment Income
23.8324.2122.5614.875.5432.26
Currency Exchange Gain (Loss)
-12.98-12.9819.759.5810.120.84
Other Non Operating Income (Expenses)
-32.38-6.62-5.21-4.41-9.23-5.48
EBT Excluding Unusual Items
123.62159.91142.03150.41118.63151.72
Impairment of Goodwill
-----15.32-5.82
Gain (Loss) on Sale of Investments
-114.54-55.88-25.494.662.6-2.43
Gain (Loss) on Sale of Assets
0.36-0.24-0.742.331.4-0.7
Asset Writedown
0.5-----0.19
Legal Settlements
---3.73-0.24--3.71
Other Unusual Items
8.326.49.681.646.966.61
Pretax Income
18.27110.19121.75158.81114.27145.49
Income Tax Expense
30.5830.1221.495.3315.2428.39
Earnings From Continuing Operations
-12.3180.07100.26153.4899.03117.1
Minority Interest in Earnings
-30.06-24.06-29.87-21.03-6.47-12.24
Net Income
-42.3756.0170.39132.4592.56104.86
Net Income to Common
-42.3756.0170.39132.4592.56104.86
Net Income Growth
--20.43%-46.86%43.09%-11.73%296.93%
Shares Outstanding (Basic)
611580566562566583
Shares Outstanding (Diluted)
611580573573566583
Shares Change
7.37%1.34%-0.03%1.19%-2.82%10.26%
EPS (Basic)
-0.070.100.120.240.160.18
EPS (Diluted)
-0.070.100.120.230.160.18
EPS Growth
--21.48%-46.84%41.41%-9.17%260.00%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
216.52154.89161.19294.5960.85115.48
Free Cash Flow Per Share
0.350.270.280.510.110.20
Dividend Per Share
0.0500.1800.1600.1000.1000.100
Dividend Growth
-70.59%12.50%60.00%0%0%100.00%
Gross Margin
38.87%38.65%38.28%36.84%33.04%33.21%
Operating Margin
10.29%10.87%8.51%9.50%7.77%9.29%
Profit Margin
-2.32%3.04%4.08%7.92%5.57%6.94%
Free Cash Flow Margin
11.83%8.41%9.35%17.62%3.66%7.64%
EBITDA
253.27260.92201.89208.85181.79183.42
EBITDA Margin
13.84%14.17%11.71%12.49%10.95%12.13%
D&A For EBITDA
64.9760.7555.1350.0352.7643.02
EBIT
188.3200.17146.77158.82129.04140.39
EBIT Margin
10.29%10.87%8.51%9.50%7.77%9.29%
Effective Tax Rate
167.37%27.33%17.65%3.36%13.34%19.51%
Revenue as Reported
1,8301,8411,7241,6721,6611,511
Advertising Expenses
-8.8213.9610.590.131.4